Cardio-renal diseases specialist Renibus Therapeutics has announced positive interim data from its lead clinical candidate, RBT-1, from its randomized, placebo- 17 June 2022
Zydus Lifesciences achieved a first this month with the Indian launch of an oral, non-statin lipid-lowering drug, bempedoic acid, under the brand name Bemdac. 27 May 2022
The race to meet sudden, stratospheric demand for new anti-obesity meds is hotting up, but Novo Nordisk CEO Lars Fruergaard Jørgensen takes a collegiate approac 26 May 2022
The European pharma industry has released a new report offering recommendations to improve outcomes for people living with a cardiovascular disease (CVD) in the 13 May 2022
Pfizer has reported first quarter revenues of $25.7 billion, well ahead of many analysts’ expectations, including the Financial Times consensus forecast of $23. 3 May 2022
Soaring AstraZeneca sales beat estimates in 2022’s first quarter, but the company’s full-year guidance remains unchanged amid an uncertain Covid-19-product sale 29 April 2022
French drugmaker Sanofi exceeded analyst estimates with its first-quarter earnings as its blockbuster immunology drug Dupixent (dupilumab) maintained its miracu 28 April 2022
Swiss pharma major Novartis edged marginally higher in the stock market on Tuesday after announcing that its first quarter sales and profits had done the same. 26 April 2022
UK biotech Forcefield Therapeutics has launched to develop drugs to protect heart function by arresting the loss of cardiomyocytes following myocardial infarcti 25 April 2022
The Japanese business of Swiss biotech Idorsia has launched Pivlaz (clazosentan), a potent, selective endothelin A (ETA) receptor antagonist which targets the r 20 April 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.